Presentations on Interview preparation, pharmaceutical guidelines and personal development.

Zydus Vadodara Warning Letter Sep 2024 | Learning through USFDA Warning Letters
12:30
Zydus Vadodara Warning Letter Sep 2024 | Learning through USFDA Warning Letters
Biocon Bangalore 483's July 2024 USFDA Inspection | Learning through 483 Observations
27:30
Biocon Bangalore 483's July 2024 USFDA Inspection | Learning through 483 Observations
Zydus Vadodara 483 Observation Apr 2024
17:32
Zydus Vadodara 483 Observation Apr 2024
Biocon Malaysia 483 Observations July 2023 | Learning from USFDA 483s
11:16
Biocon Malaysia 483 Observations July 2023 | Learning from USFDA 483s
Nitrosamine Impurities-Aug 2023 NDSRIs Limit USFDA Guidance | Control of Nitrosamine Guidance Feb-21
44:52
Nitrosamine Impurities-Aug 2023 NDSRIs Limit USFDA Guidance | Control of Nitrosamine Guidance Feb-21
Medgel Pharma Indore Warning Letter 20 July 2023 | Learning from USFDA Warning Letters
8:09
Medgel Pharma Indore Warning Letter 20 July 2023 | Learning from USFDA Warning Letters
Baxter Pharma Warning Letter 25 July 2023 Ahmedabad | Learning from USFDA Warning Letters
10:32
Baxter Pharma Warning Letter 25 July 2023 Ahmedabad | Learning from USFDA Warning Letters
Intas Pharma Warning Letter 28 July 2023 | Learning from USFDA Warning Letters | 2023 Warning Letter
19:03
Intas Pharma Warning Letter 28 July 2023 | Learning from USFDA Warning Letters | 2023 Warning Letter
QR Code for Top 300 Medicines in India | Government of India Directive to Curb counterfeit drugs
5:45
QR Code for Top 300 Medicines in India | Government of India Directive to Curb counterfeit drugs
Ipca Laboratories Indore USFDA 483 June 2023 | learning from 483's
15:20
Ipca Laboratories Indore USFDA 483 June 2023 | learning from 483's
USFDA Inspections: Overview | Difference between USFDA Inspection & Other Authority Inspections
20:52
USFDA Inspections: Overview | Difference between USFDA Inspection & Other Authority Inspections
Centaur Pharma Warning Letter June 2023 USFDA | Learning from Warning Letter
12:21
Centaur Pharma Warning Letter June 2023 USFDA | Learning from Warning Letter
Intas Ahmedabad 483 Observation May 2023 | Learning from 483s
1:04:14
Intas Ahmedabad 483 Observation May 2023 | Learning from 483s
IPCA Laboratories Ratlam 483 Observation June 2023 | Learning from Observations | API Facility
35:40
IPCA Laboratories Ratlam 483 Observation June 2023 | Learning from Observations | API Facility
Revised ICH Q9 (R1) Quality Risk Management Guideline | Jan 2023
26:38
Revised ICH Q9 (R1) Quality Risk Management Guideline | Jan 2023
Quality Metrics Data Submission USFDA Guidance| USFDA Guidelines |
30:33
Quality Metrics Data Submission USFDA Guidance| USFDA Guidelines |
ICH Q12 Product Lifecycle Management
38:26
ICH Q12 Product Lifecycle Management
ICH Q3C Guidance for Residual Solvents | Class of Residual Solvents | PDE Values of Residual Solvent
17:22
ICH Q3C Guidance for Residual Solvents | Class of Residual Solvents | PDE Values of Residual Solvent
21 CFR Part 11 | Electronic Records & Electronic Signatures | GxP Computer System requirements
25:27
21 CFR Part 11 | Electronic Records & Electronic Signatures | GxP Computer System requirements
Revised EU Annex 1- Manufacture of Sterile Products (25 Aug 2022) | Comprehensive Training Module
2:19:07
Revised EU Annex 1- Manufacture of Sterile Products (25 Aug 2022) | Comprehensive Training Module
ICH Q3D Guidance for Elemental Impurities | Example for calculating | Permitted Daily Dose (PDE)
34:21
ICH Q3D Guidance for Elemental Impurities | Example for calculating | Permitted Daily Dose (PDE)
Revised Out of Specification (OOS) Guidance | USFDA Guidance | OOS Guidance May 2022
19:37
Revised Out of Specification (OOS) Guidance | USFDA Guidance | OOS Guidance May 2022
ICH Q9 Guidance for Quality Risk Management | With simplified example
31:28
ICH Q9 Guidance for Quality Risk Management | With simplified example
USFDA Guidance for Data Integrity | USFDA Guidelines for Pharmaceutical | Easy Explanation
19:06
USFDA Guidance for Data Integrity | USFDA Guidelines for Pharmaceutical | Easy Explanation
ICH Q10 Guidance for Pharmaceutical Quality System | Guideline for Pharmaceutical Industry
22:21
ICH Q10 Guidance for Pharmaceutical Quality System | Guideline for Pharmaceutical Industry
USFDA Guidance for Pharmaceutical Quality System | USFDA Guidelines for Pharmaceuticals |
22:36
USFDA Guidance for Pharmaceutical Quality System | USFDA Guidelines for Pharmaceuticals |
How to answer the interview question on 'What are your strengths?' | Interview question
4:51
How to answer the interview question on 'What are your strengths?' | Interview question
Don'ts of Interview | Things not to talk about in the interview
8:00
Don'ts of Interview | Things not to talk about in the interview
How to prepare for interview | Tips for Interview Preparation | 5 Steps for Interview Preparation
9:07
How to prepare for interview | Tips for Interview Preparation | 5 Steps for Interview Preparation
How to introduce youself in interview | Tell me about yourself | Describe Yourself | Interview Prep
7:32
How to introduce youself in interview | Tell me about yourself | Describe Yourself | Interview Prep